UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000013323
Receipt number R000015547
Scientific Title liver signal profiling and blood marker research for non-alcoholic fatty liver diseases
Date of disclosure of the study information 2014/03/04
Last modified on 2020/10/09 09:09:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

liver signal profiling and blood marker research for non-alcoholic fatty liver diseases

Acronym

liver signal profiling and blood marker research for non-alcoholic fatty liver diseases

Scientific Title

liver signal profiling and blood marker research for non-alcoholic fatty liver diseases

Scientific Title:Acronym

liver signal profiling and blood marker research for non-alcoholic fatty liver diseases

Region

Japan


Condition

Condition

nonalcoholic fatty liver diseases

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To elucidate the factors associated with pathogenesis and development of nonalcoholic steatohepatitis (NASH) by the profiling of liver and blood collected from nonalcoholic steatohepatitis (NAFLD) patients, furthermore to research the early diagnostic procedure of NASH and create a therapeutic medication for NASH.

Basic objectives2

Others

Basic objectives -Others

Diagnosis and treatment

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

1) Proceeding Genechip analysis, Methylation BeadChip analysis, and comprehensive analysis of miRNA for signal profiling in liver by using liver biopsy samples collected in each trial sites
2) Proceeding Proteomics analysis, metabolomics analysis, and comprehensive analysis of miRNA to research diagnostic markers for NASH by using blood samples collected in each trial sites

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients with suspected NAFLD by interview, blood collection, imaging studies

Key exclusion criteria

1) Persons over 20g per day or 140g per week of alcohol intake
2) Patients who are suspicious of viral hepatitis, autoimmune hepatitis, primary biliary cirrhosis, sclerosing cholangitis, hemochromatosis, alpha1-antitrypsin deficiency, Wilson's disease, drug-induced hepatitis
3) Patients who showed clinical evidence of hepatic decompensation such as hepatic encephalopathy, ascites, variceal bleeding, or a serum bilirubin level greater than twofold the normal upper limit
4) Persons judged inappropriate for this study

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Yuichiro
Middle name
Last name Eguchi

Organization

Saga University Hospital

Division name

Division of Hepatology

Zip code

849-8501

Address

5-1-1 Nabeshima, Saga 849-8501, Japan

TEL

0952-34-3010

Email

eguchiyu@cc.saga-u.ac.jp


Public contact

Name of contact person

1st name Yuichiro
Middle name
Last name Eguchi

Organization

Saga University Hospital

Division name

Division of Hepatology

Zip code

849-8501

Address

5-1-1 Nabeshima, Saga 849-8501, Japan

TEL

0952-34-3010

Homepage URL


Email

eguchiyu@cc.saga-u.ac.jp


Sponsor or person

Institute

Saga Medical School
Hiroshima University
Yokohama City University Graduate School of Medicine
Takeda Pharmaceutical Company

Institute

Department

Personal name



Funding Source

Organization

Saga Uiversity

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Saga Uiversity

Address

5-1-1 Nabeshima, Saga 849-8501, Japan

Tel

0952-34-3010

Email

eguchiyu@cc.saga-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

佐賀大学病院(佐賀県)、広島大学病院(広島県)、横浜市立大学病院(神奈川県)、武田薬品工業株式会社(神奈川県)


Other administrative information

Date of disclosure of the study information

2014 Year 03 Month 04 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2013 Year 10 Month 01 Day

Date of IRB

2013 Year 10 Month 25 Day

Anticipated trial start date

2014 Year 02 Month 28 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This study is observational study.
Samples are collected from patients with suspected NAFLD by interview, blood collection, imaging studies. In some cases, samples are collected two or more times from the same person.
Analysis is conducted prospectively with the samples collected after the date of registration.


Management information

Registered date

2014 Year 03 Month 04 Day

Last modified on

2020 Year 10 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015547


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name